Paper41398167
Heterologous combinations of VSV-GP and native-like trimers elicit autologous Tier 2 HIV antibodies in rabbits.
Radvan F and 15 others. NPJ Vaccines, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Heterologous combinations of VSV-GP and native-like trimers elicit autologous Tier 2 HIV antibodies in rabbits. Papers, record 41398167. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41398167
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Heterologous combinations of VSV-GP and native-like trimers elicit autologous Tier 2 HIV antibodies in rabbits.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 681032 (EHVA, European HIV Vaccine Alliance) | EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) | PubMed | ||
| Project HIVacToGC, Grant 16GW0363K | Bundesministerium für Bildung und Forschung (Federal Ministry of Education and Research) | PubMed |
Source PubMed
References50
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33290394 | RV144 HIV-1 vaccination impacts post-infection antibody responses. | PLoS Pathog | 2020 | https://conductscience.org/library/papers/33290394 | PubMed |
| 2 | 18833271 | Challenges in the development of an HIV-1 vaccine. | Nature | 2008 | https://conductscience.org/library/papers/18833271 | PubMed |
| 3 | 40260855 | An HIV Vaccine in the Era of Twice-Yearly Lenacapavir for PrEP - Essential or Irrelevant? | N Engl J Med | 2025 | https://conductscience.org/library/papers/40260855 | PubMed |
| 4 | 24554655 | VSV-GP: a potent viral vaccine vector that boosts the immune response upon repeated applications. | J Virol | 2014 | https://conductscience.org/library/papers/24554655 | PubMed |
| 5 | 31921191 | Heterologous Combination of VSV-GP and NYVAC Vectors Expressing HIV-1 Trimeric gp145 Env as Vaccination Strategy to Induce Balanced B and T Cell Immune Responses. | Front Immunol | 2019 | https://conductscience.org/library/papers/31921191 | PubMed |
| 6 | 19843557 | Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. | N Engl J Med | 2009 | https://conductscience.org/library/papers/19843557 | PubMed |
| 7 | 16051804 | Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies. | J Virol | 2005 | https://conductscience.org/library/papers/16051804 | PubMed |
| 8 | 25892233 | Cleavage-independent HIV-1 Env trimers engineered as soluble native spike mimetics for vaccine design. | Cell Rep | 2015 | https://conductscience.org/library/papers/25892233 | PubMed |
| 9 | 18815292 | Profiling the specificity of neutralizing antibodies in a large panel of plasmas from patients chronically infected with human immunodeficiency virus type 1 subtypes B and C. | J Virol | 2008 | https://conductscience.org/library/papers/18815292 | PubMed |
| 10 | 17699567 | Early antibodies specific for the neutralizing epitope on the receptor binding subunit of the lymphocytic choriomeningitis virus glycoprotein fail to neutralize the virus. | J Virol | 2007 | https://conductscience.org/library/papers/17699567 | PubMed |
| 11 | 9466515 | Cytotoxic T cell and neutralizing antibody responses to human immunodeficiency virus type 1 envelope with a combination vaccine regimen. AIDS Vaccine Evaluation Group. | J Infect Dis | 1998 | https://conductscience.org/library/papers/9466515 | PubMed |
| 12 | 32554928 | Protein-based, but not viral vector alone, HIV vaccine boosting drives an IgG1-biased polyfunctional humoral immune response. | JCI Insight | 2020 | https://conductscience.org/library/papers/32554928 | PubMed |
| 13 | 35778473 | Comparing methods for immobilizing HIV-1 SOSIPs in ELISAs that evaluate antibody binding. | Sci Rep | 2022 | https://conductscience.org/library/papers/35778473 | PubMed |
| 14 | 32313928 | A Randomized Dose-Escalating Phase I Trial of a Replication-Deficient Lymphocytic Choriomeningitis Virus Vector-Based Vaccine Against Human Cytomegalovirus. | J Infect Dis | 2022 | https://conductscience.org/library/papers/32313928 | PubMed |
| 15 | 12019106 | Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. | Antimicrob Agents Chemother | 2002 | https://conductscience.org/library/papers/12019106 | PubMed |
| 16 | 35783486 | Safety and immunogenicity of an HIV-1 prefusion-stabilized envelope trimer (Trimer 4571) vaccine in healthy adults: A first-in-human open-label, randomized, dose-escalation, phase 1 clinical trial. | EClinicalMedicine | 2022 | https://conductscience.org/library/papers/35783486 | PubMed |
| 17 | 37777519 | Assessing immunogenicity barriers of the HIV-1 envelope trimer. | NPJ Vaccines | 2023 | https://conductscience.org/library/papers/37777519 | PubMed |
| 18 | 34465781 | A modular self-adjuvanting cancer vaccine combined with an oncolytic vaccine induces potent antitumor immunity. | Nat Commun | 2021 | https://conductscience.org/library/papers/34465781 | PubMed |
| 19 | 11861826 | Enhancing the proteolytic maturation of human immunodeficiency virus type 1 envelope glycoproteins. | J Virol | 2002 | https://conductscience.org/library/papers/11861826 | PubMed |
| 20 | 24812275 | Re-engineering vesicular stomatitis virus to abrogate neurotoxicity, circumvent humoral immunity, and enhance oncolytic potency. | Cancer Res | 2014 | https://conductscience.org/library/papers/24812275 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41398167
GET https://conductscience.org/api/papers/v1/41398167/references?page=2